Description

Description

Amodip-V Plus 10/160/12.5mg is a high-strength triple-combination tablet manufactured by Mass Pharma, containing Amlodipine, Valsartan, and Hydrochlorothiazide together in one once-daily dose. This particular strength, featuring the higher 10mg dose of Amlodipine alongside the maximum strengths of Valsartan and Hydrochlorothiazide found in this product line, is generally reserved for patients with more resistant or persistent hypertension who have not achieved sufficient blood pressure control with lower-dose triple therapy or dual combinations. The three ingredients work through distinct but complementary mechanisms: Amlodipine, a calcium channel blocker, relaxes the muscles within blood vessel walls to ease blood flow; Valsartan, an angiotensin receptor blocker, blocks a hormone responsible for narrowing blood vessels; and Hydrochlorothiazide, a thiazide diuretic, assists the kidneys in removing excess salt and water, thereby reducing fluid volume in the circulatory system. Combining higher doses of all three within a single tablet offers a more potent, comprehensive approach to blood pressure management while keeping the daily routine simple. Each pack of Amodip-V Plus 10/160/12.5mg contains 14 tablets, intended for long-term use under a physician’s supervision.

Ingredients

Each Amodip-V Plus 10/160/12.5mg tablet contains three active pharmaceutical ingredients: Amlodipine at 10mg, Valsartan at 160mg, and Hydrochlorothiazide at 12.5mg. The formulation also includes standard inactive excipients, such as fillers, binding agents, and a film-coating layer, which contribute to the tablet’s physical stability and ease of swallowing without affecting its therapeutic action.

Dosage Form

Amodip-V Plus 10/160/12.5mg is available as a film-coated oral tablet, combining 10mg of Amlodipine, 160mg of Valsartan, and 12.5mg of Hydrochlorothiazide in each unit. The tablets are supplied in blister packaging, with 14 tablets per pack, for oral administration only.

Uses

Amodip-V Plus 10/160/12.5mg is primarily prescribed for patients with hypertension that has not responded adequately to lower-strength triple-combination therapy or to dual combinations of these ingredients. By delivering higher doses of a calcium channel blocker, an angiotensin receptor blocker, and a diuretic together, this medicine provides a more intensive approach to lowering blood pressure, which helps reduce the long-term risks associated with poorly controlled hypertension, such as stroke, heart attack, and progressive kidney damage. It is typically used as part of a comprehensive treatment plan that also includes lifestyle and dietary adjustments guided by a healthcare provider.

How to Use

This medication should be taken exactly as prescribed by a physician who is familiar with the patient’s complete treatment history. It is generally taken once daily, at a consistent time, with or without food, though earlier in the day is often preferred to minimize nighttime urination associated with its diuretic component. The tablet should be swallowed whole with a sufficient amount of water and should not be crushed, split, or chewed unless a doctor or pharmacist has specifically advised otherwise. Since this is a high-strength triple-combination medicine intended for long-term management, doses should not be skipped, and treatment should never be stopped abruptly without medical consultation, even when blood pressure appears well controlled. If a dose is missed, it should be taken as soon as remembered, unless the next dose is nearly due, in which case the missed dose should be skipped rather than doubled.

Side Effects

Because this tablet combines higher doses of three active ingredients, patients may be more likely to experience noticeable side effects compared to lower-strength versions, although individual responses vary considerably. Commonly reported effects include dizziness, headache, fatigue, increased urination, and swelling of the ankles or feet, which may be more pronounced due to the higher Amlodipine dose. Some patients may experience symptoms of low blood pressure, such as lightheadedness upon standing, particularly when treatment begins or doses are adjusted. Less frequently, effects such as muscle cramps, nausea, or disturbances in electrolyte levels, including low sodium or potassium and, in some cases, elevated potassium, may occur due to the combined effects of Valsartan and Hydrochlorothiazide. In rare cases, more serious reactions such as severe allergic responses, significant drops in blood pressure, irregular heart rhythm, or signs of reduced kidney function may develop, requiring prompt medical attention. Regular blood tests to monitor electrolyte balance and kidney function are often recommended throughout treatment. Patients should inform their doctor promptly of any unusual, severe, or persistent symptoms.

Pregnancy & Breastfeeding

Amodip-V Plus should not be used during pregnancy without explicit medical guidance, as both Valsartan and Hydrochlorothiazide are generally avoided during pregnancy due to potential risks to fetal development, particularly beyond the first trimester. Breastfeeding mothers should also seek medical advice before taking this medication, since all three active ingredients may pass into breast milk, and their combined safety during lactation needs to be evaluated individually. Any patient who becomes pregnant while taking this medicine should inform her doctor immediately so treatment can be reassessed.

Storage Instructions

Amodip-V Plus tablets should be stored in a cool, dry place, protected from direct sunlight and excess humidity. It is best to keep the tablets in their original blister packaging until they are needed, and to store them securely out of the reach of children and pets. Tablets should not be used after the expiry date printed on the packaging.

FAQs

Who is typically prescribed this higher-strength triple combination?
This strength is generally reserved for patients with more resistant hypertension who have not achieved target blood pressure levels with lower-dose triple therapy or dual-combination treatments.

Are side effects more likely at this higher dose?
Some dose-related effects, particularly swelling, dizziness, and electrolyte changes, may be more noticeable at this strength, so patients should monitor their response closely and report concerns to their doctor.

How often should I have blood tests while on this medication?
Your doctor will determine an appropriate monitoring schedule, but regular checks of kidney function, electrolytes, and blood pressure are commonly recommended given the potency of this combination.

Can this medication be used as a first-line treatment for hypertension?
It is typically prescribed after other treatment options have been tried, rather than as an initial therapy, since it delivers a more intensive combination of active ingredients.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.